NEW YORK (GenomeWeb) – Enzo Biochem today announced that it has received a favorable claim construction ruling that will govern 10 ongoing patent suits the firm has brought to defend three US patents.

The firm said the US District Court for the District of Delaware has adopted Enzo's proposed constructions for the majority of the disputed claim terms and rejected the defendants' argument that Enzo's US Patent No. 6,992,180 for phosphate-moiety labeled oligonucleotide reagents is invalid for indefiniteness.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.